Literature DB >> 18607526

Blocking kinetics of memantine on NR1a/2A receptors recorded in inside-out and outside-out patches from Xenopus oocytes.

Chris G Parsons1, Kate E Gilling, Claudia Jatzke.   

Abstract

Previous experiments on primary cultures of hippocampal/cortical neurones revealed that the block and unblock of N-Methyl-D-Aspartate (NMDA) receptor channels by memantine showed double exponential kinetics and that the offset kinetics following a voltage-step were much faster than following a concentration jump. There are, however, two major problems when using such cultured primary neurones for these experiments (1) the almost certain expression of heterogeneous NMDA receptor subunits which could underlie double exponential kinetics due to different potencies at receptor subtypes and (2) slow space- and concentration-clamp due to neuronal morphology which could mask even faster kinetics. Therefore, we performed similar experiments with Xenopus oocytes exclusively expressing one NMDA receptor type (NR1a/2A) at high levels which allowed recordings from membrane patches with large currents. The use of inside-out patches for voltage-step and outside-out patches in combination with a piezo driven fast application system largely negated potential space- and concentration-clamp problems. Block and unblock of the NMDA receptor by memantine after both voltage jump and concentration jumps showed triple exponential kinetics. The fast onset kinetics of NMDA receptor channel block following both concentration-clamp and voltage jumps from +70 to -70 mV were similar. In contrast, offset kinetics after a voltage-step from -70 to +70 mV were much faster than following a concentration jump at the holding potential of -70 mV. These results provide further support for the hypothesis that rapid relief of block via strong synaptic membrane depolarisation underlies the good therapeutic profile of memantine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18607526     DOI: 10.1007/s00702-008-0087-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  28 in total

1.  Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.

Authors:  Bodo Laube; Rudolf Schemm; Heinrich Betz
Journal:  Neuropharmacology       Date:  2004-12       Impact factor: 5.250

Review 2.  Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines.

Authors:  M A Rogawski
Journal:  Trends Pharmacol Sci       Date:  1993-09       Impact factor: 14.819

3.  Revisiting the postulated "unitary glutamate receptor": electrophysiological and pharmacological analysis in two heterologous expression systems fails to detect evidence for its existence.

Authors:  Carsten Schmidt; Markus Werner; Michael Hollmann
Journal:  Mol Pharmacol       Date:  2005-10-07       Impact factor: 4.436

4.  Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.

Authors:  C G Parsons; W Danysz; A Bartmann; P Spielmanns; T Frankiewicz; M Hesselink; B Eilbacher; G Quack
Journal:  Neuropharmacology       Date:  1999-01       Impact factor: 5.250

5.  Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

Authors:  J Kornhuber; J Bormann; M Hübers; K Rusche; P Riederer
Journal:  Eur J Pharmacol       Date:  1991-04-25       Impact factor: 4.432

6.  Two blocking sites of amino-adamantane derivatives in open N-methyl-D-aspartate channels.

Authors:  A Sobolevsky; S Koshelev
Journal:  Biophys J       Date:  1998-03       Impact factor: 4.033

Review 7.  Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.

Authors:  C G Parsons; W Danysz; G Quack
Journal:  Neuropharmacology       Date:  1999-06       Impact factor: 5.250

8.  Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Authors:  Pierre N Tariot; Martin R Farlow; George T Grossberg; Stephen M Graham; Scott McDonald; Ivan Gergel
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

9.  Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).

Authors:  C G Parsons; R Gruner; J Rozental; J Millar; D Lodge
Journal:  Neuropharmacology       Date:  1993-12       Impact factor: 5.250

10.  Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine.

Authors:  K E Gilling; C Jatzke; C G Parsons
Journal:  Neuropharmacology       Date:  2007-06-07       Impact factor: 5.250

View more
  3 in total

1.  Effects of Mg2+ on recovery of NMDA receptors from inhibition by memantine and ketamine reveal properties of a second site.

Authors:  Nathan G Glasgow; Madeleine R Wilcox; Jon W Johnson
Journal:  Neuropharmacology       Date:  2018-05-12       Impact factor: 5.250

2.  Inhibition of NMDA receptors through a membrane-to-channel path.

Authors:  Madeleine R Wilcox; Aparna Nigam; Nathan G Glasgow; Chamali Narangoda; Matthew B Phillips; Dhilon S Patel; Samaneh Mesbahi-Vasey; Andreea L Turcu; Santiago Vázquez; Maria G Kurnikova; Jon W Johnson
Journal:  Nat Commun       Date:  2022-07-15       Impact factor: 17.694

3.  Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones.

Authors:  A R Wild; E Akyol; S L C Brothwell; P Kimkool; J N Skepper; A J Gibb; S Jones
Journal:  Neuropharmacology       Date:  2013-05-28       Impact factor: 5.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.